1. Clinical Immunology Department, Hôpital Saint Louis, Université de Paris, Paris, France;
2. Sorbonne Université, INSERM UMRS_938, Saint-Antoine Research Centre, IHU ICAN, Paris, France;
3. Biochemistry Laboratory, Hôpital Henri Mondor, Créteil, France;
4. Endocrinology Department, Hôpital Lariboisière, and
5. National Reference Center for Castleman disease, Hôpital Saint Louis, Université de Paris, Paris, France;
6. Endocrinology Department, CHU Nantes, Nantes, France;
7. Rheumatology Department, CHU Nice, Nice, France;
8. Immunology and Histocompatibility Laboratory, Hôpital Saint Louis, Université de Paris, Paris, France;
9. Department of Endocrinology and
10. Department of Molecular Biology and Genetics, Assistance Publique–Hôpitaux de Paris, Saint Antoine Hospital, National Reference Centre for Rare Diseases of Insulin Secretion and Insulin Sensitivity (PRISIS), Paris, France; and
11. U976 HIPI, INSIGHT team, Hôpital Saint Louis, Université de Paris, Paris, France